|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.0800 - 2.3500|
|52 Week Range||1.9200 - 5.8000|
|Beta (3Y Monthly)||3.64|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 13, 2019 - Aug 19, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MariMed Inc. continues to experience the positive fundamental trends in its operating results as reported over the last several quarters, driven by executing its strategic plan for expansion on many fronts in both the cannabis and hemp-based CBD markets. This former director had no involvement in the day to day management or operations of the Company and his departure had been anticipated for some time. The Company is actively looking to replace him and has identified several qualified candidates.
Penelope Finnie, Senior Vice President of Marketing and Branding at MariMed, stated, “Over the past year, MariMed has expanded beyond its advisory service origins with new sales and production facilities, product expansion, strategic acquisitions, key executive hires, and the launch of a wholly-owned subsidiary, MariMed Hemp, focused on hemp-based CBD markets. MariMed, Inc. is dedicated to improving health and wellness with the highest quality hemp and cannabis products. The company offers a full range of cannabis products, operates state of the art cannabis dispensaries in six states, and has a separate division, MariMed Hemp, focused on the development of industrial hemp-derived CBD products.
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...
NORWOOD, MA, May 13, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD) one of the largest multi-state cannabis operators in the US, today announced 2019 first quarter results for the period ending March 31, 2019. Continued Strong Revenue Growth and Improved Operating Performance - In the first quarter ended March 31, 2019, revenues grew 69% to $3.5 million, compared to $2.1 million for the first quarter of 2018. Gross profit grew 90% to $2.2 million vs. $1.2 million for the first quarter of 2018 compared to the same period in 2018.
NORWOOD, MA, May 09, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD) a leading multi-state cannabis and hemp operator in the US, announced today that MariMed CEO Bob Fireman will present at two cannabis investor conferences in New York City, May 14th and 15th. On Wednesday, May 14th, MariMed CEO Bob Fireman will present a company overview at 3:20 PM at the Canaccord Annual Cannabis Conference at the Grand Hyatt in New York City.
MariMed Inc. (MRMD) one of the largest multi-state cannabis and hemp operators in the US, announced today that its Chief Information Officer, Dr. Jokūbas Žiburkus, will be presenting at the 3rd Institutional Capital & Cannabis Conference held in Los Angeles, CA, May 9-10, 2019. MariMed CEO Bob Fireman noted, “Dr. Žiburkus has long been an innovator and thought leader in research and education on beneficial effects of cannabis compounds for a variety of health conditions.
The Land of Lincoln could soon be the land of legal recreational marijuana -- and these three stocks should be winners as a result.
Investors and major cannabis execs were in the same room April 17-18 at Benzinga's Cannabis Capital Conference in Toronto. Cannabis has the "power to transform human and wellness," said Robert Fireman, president and CEO of Marimed Inc (OTC: MRMD). One of the ways the medical cannabis company makes its mark is by offering a pure CBD product to treat children suffering from epilepsy, he said.
Marimed Inc (OTCMKTS:MRMD), a major US. hemp and cannabis operator, announced on Thursday that it plans to buy 70% of MediTaurus stake and the transaction will be handled by its MariMed Hemp subsidiary. MediTaurus holds numerous intellectual property patents for cannabis formulations and it also owns the Florance CBD health brand. The latter has a […]The post Marimed To Purchase 70% Of MediTaurus appeared first on Market Exclusive.
MariMed Inc. (MRMD) one of the largest multi-state cannabis and hemp operators in the U.S., today announced that its MariMed Hemp subsidiary will acquire 70% of MediTaurus, LLC, owner of the international Florance™ brand of CBD health and wellness products and extensive intellectual property (IP) relating to cannabis formulations. This is the first acquisition for MariMed Hemp, which was formed to optimize MariMed’s strategic investment in GenCanna Global, Inc., the Kentucky-based producer of compliant, quality CBD derived from hemp. MediTaurus CEO and Co-founder Dr. Jokūbas Žiburkus will join the MariMed executive team as Chief Innovation Officer and an advisor on scientific research and education.
NORWOOD, April 17, 2019 (GLOBE NEWSWIRE) -- – MariMed Inc. (MRMD) one of the largest multi-state cannabis and hemp operators in the U.S., today announced 2018 4th Quarter and Full Year results. Continued Strong Revenue Growth - In the fourth quarter ended December 31, 2018, revenues grew 118% to $3.44 million, compared to $1.58 million in 2017.
CORAL GABLES, FL / ACCESSWIRE / April 11, 2019 / The marijuana stock market has become quite dominated by companies that are working out of either the U.S. or Canadian cannabis space. Given the tidal shift in public opinion surrounding cannabis, companies in the cannabis industry have recently ramped up production to give consumers the products they need. With so much opportunity coming out of the cannabis industry, it seems as though there are no signs of slowing anytime soon.
MariMed Inc. (MRMD) one of the largest multi-state cannabis and hemp operators in the US, announced today that it will be presenting at the Benzinga Cannabis Capital Conference held in Toronto, Canada April 17-18. On Thursday April 18, MariMed CEO Bob Fireman will present a company overview at 1:00PM in the Quebec Room of the Fairmont Royal York Hotel, 100 Front Street West in Toronto.
Such late resignation by the Former Audit Form did not leave enough time for the Company’s and its new audit firm (the “New Audit Firm”) to plan and perform a proper year-end audit in accordance with the standards of the Public Company Accounting Oversight Board. Accordingly, the New Audit Firm asked the Company to file this notification of late filing so they could complete their audit.
MariMed Inc. (MRMD) a leading multi-state cannabis and hemp operator, today announced an agreement with Ilo™ Vapor whereby MariMed is an exclusive distributor of the company’s flagship product, DabTab™ brand dablets. The product is available now to all cannabis dispensaries in Maryland. It will be introduced to Rhode Island, Massachusetts and Delaware dispensaries later this spring.
-The illicit cannabis industry is estimated at $50 billion yearly, much of which will move out of the shadows and become a legal market in the coming years. One research firm estimates the legal trade could be worth $21 billion by 2021. - Item 9 Labs (INLB) could be one of these as they finish a major expansion project on their Arizona cannabis cultivation and production facility, doubling capacity.
OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ -- OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...
MariMed Inc. (MRMD) a multi-state cannabis operator and hemp CBD product producer, announced today that it will be appearing at two investment conferences in March. On Wednesday, March 6, MariMed senior management will attend the Opal Group’s Family Office Winter Forum held at the Marriott Marquis Hotel in Times Square, New York City. It is one of the largest family office events in the U.S. Additionally, MariMed CEO Bob Fireman will participate in a 4:00 PM panel discussion focusing on investing in the cannabis industry.
MariMed Inc. (MRMD), one of the largest multi-state cannabis operators in the U.S., announced today that pursuant to its November 2018 agreement with GenCanna Global USA, Inc., a recognized innovator and cultivator of industrial hemp, MariMed has converted its initial $30 million purchase of debentures into GenCanna common stock.
As we see what February has in store, Leafbuyer Technologies Inc (OTC:LBUY), MariMed Inc (MRMD), Tilray Inc (TLRY), and INSYS Therapeutics (INSY) are 4 pot stocks worth looking into on Tuesday. Leafbuyer Technologies Inc (OTC:LBUY) is one of the leading online resources for those in the cannabis industry. The Company, through its subsidiary, LB Media Group LLC, operates an online platform for trending cannabis deals and specials and has been lauded as the most comprehensive source for ascertaining cannabis-related information.